chr15-101021111-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_024652.6(LRRK1):c.1668C>T(p.Asn556Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.013 in 1,614,058 control chromosomes in the GnomAD database, including 2,131 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.067 ( 1119 hom., cov: 31)
Exomes 𝑓: 0.0074 ( 1012 hom. )
Consequence
LRRK1
NM_024652.6 synonymous
NM_024652.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.72
Genes affected
LRRK1 (HGNC:18608): (leucine rich repeat kinase 1) This gene encodes a multi-domain protein that is a leucine-rich repeat kinase and a GDP/GTP binding protein. The encoded protein is thought to play a role in the regulation of bone mass. Mice lacking a similar gene showed severe osteopetrosis, increased bone mineralization and decreased bone resorption. [provided by RefSeq, Jan 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 15-101021111-C-T is Benign according to our data. Variant chr15-101021111-C-T is described in ClinVar as [Benign]. Clinvar id is 1623610.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.72 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.226 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRK1 | NM_024652.6 | c.1668C>T | p.Asn556Asn | synonymous_variant | 13/34 | ENST00000388948.8 | NP_078928.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRK1 | ENST00000388948.8 | c.1668C>T | p.Asn556Asn | synonymous_variant | 13/34 | 5 | NM_024652.6 | ENSP00000373600.3 | ||
LRRK1 | ENST00000525284.5 | n.1668C>T | non_coding_transcript_exon_variant | 12/33 | 1 | ENSP00000433069.1 | ||||
LRRK1 | ENST00000531270.5 | n.1668C>T | non_coding_transcript_exon_variant | 12/32 | 1 | ENSP00000431668.1 |
Frequencies
GnomAD3 genomes AF: 0.0667 AC: 10144AN: 152110Hom.: 1114 Cov.: 31
GnomAD3 genomes
AF:
AC:
10144
AN:
152110
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0175 AC: 4361AN: 249582Hom.: 451 AF XY: 0.0132 AC XY: 1794AN XY: 135410
GnomAD3 exomes
AF:
AC:
4361
AN:
249582
Hom.:
AF XY:
AC XY:
1794
AN XY:
135410
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00739 AC: 10803AN: 1461830Hom.: 1012 Cov.: 31 AF XY: 0.00640 AC XY: 4651AN XY: 727232
GnomAD4 exome
AF:
AC:
10803
AN:
1461830
Hom.:
Cov.:
31
AF XY:
AC XY:
4651
AN XY:
727232
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0668 AC: 10172AN: 152228Hom.: 1119 Cov.: 31 AF XY: 0.0651 AC XY: 4845AN XY: 74438
GnomAD4 genome
AF:
AC:
10172
AN:
152228
Hom.:
Cov.:
31
AF XY:
AC XY:
4845
AN XY:
74438
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
42
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
LRRK1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 23, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at